跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
UFT CAPSULE
Approved
THERAPEUTIC
UFT CAPSULE
TAIHO PHARMACEUTICAL CO LTD (JAPAN)
🇸🇬 Health Sciences Authority
Approval Date
Sep 22, 1989
Approval ID
33ad70c7a710462b
Company
TAIHO PHARMACEUTICAL CO LTD (JAPAN)
Type
Therapeutic
Approval Details
Approval Id
33ad70c7a710462b
Drug Name
UFT CAPSULE
Product Name
UFT CAPSULE
Approval Number
SIN03692P
Approval Date
1989-09-22
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
L01BC53
Atc Item Name
tegafur, combinations
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
TEGAFUR
100 mg
URACIL
224 mg
TEGAFUR
100 mg
URACIL
224 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 22, 1989
Approval ID
33ad70c7a710462b
Type
Therapeutic
Back to HSA Approvals
UFT CAPSULE - HSA Drug Approval Details